Dose Escalation, Randomized Controlled Trial to Evaluate the Safety, Immunogenicity and Efficacy of Intravenously Administered Attenuated Plasmodium Falciparum Sporozoite Vaccine (PfSPZ Vaccine) in Tanzanian Adults
Clinical trial NCT02132299 · COMPLETED
Trial details
- NCT number
- NCT02132299
- Sponsor
- Sanaria Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2015-07-01
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.